A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic Conjunctivitis

NCT05265910 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Conjunctivitis

Interventions

DRUG: olopatadine hydrochloride ophthalmic solution 0.7%
DRUG: loratadine 10 mg
DRUG: Tears Naturale
DRUG: Placebo

Sponsor

Andover Research Eye Institute